Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM163B encodes a single-pass transmembrane protein predominantly expressed in neurons in the central nervous system. Its expression is highest in brain tissue, with very low or absent expression elsewhere. FAM163B is localized to the neuronal cell membrane and is implicated in neuroregulatory processes, though its precise function remains incompletely understood. Overexpression or knockdown experiments in neuronal cells show that FAM163B negatively regulates the membrane-associated synaptic scaffolding protein SAP97 and interacts with the vesicle-associated membrane protein VAPA, suggesting a role in neuronal membrane dynamics and possibly synaptic function. There is no evidence that FAM163B is currently a direct therapeutic target, nor are there known drugs acting on it. Its gene (HGNC:33277, NCBI Gene:642968) has been linked to autosomal dominant deafness, but broader disease implications remain unclear.
Not applicable (no known drugs)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 163 member B (FAM163B).